AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 297: F301-F306, 2009. First published June 3, 2009; doi:10.1152/ajprenal.00009.2009
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/2/F301    most recent
00009.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wiessner, J. H.
Right arrow Articles by Mandel, N. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiessner, J. H.
Right arrow Articles by Mandel, N. S.

Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains

John H. Wiessner,1,4 Michael R. Garrett,1,2 Richard J. Roman,1,3 and Neil S. Mandel1,4

1Kidney Disease Center, Departments of 2Medicine and 3Physiology, Medical College of Wisconsin and the 4Department of Veterans Affairs Medical Center, Milwaukee, Wisconsin

Submitted 6 January 2009 ; accepted in final form 2 June 2009

Whether genetics may play a role in the pathophysiologic response of kidney tubules to oxalate exposure remains unexplored despite that as many as 15% of the U.S. population annually will experience a kidney stone composed of calcium oxalate. To explore this issue, we utilized a panel of chromosome substitution strains in which one chromosome at a time was transferred from the Brown Norway (BN) rat onto the Dahl salt-sensitive (SS) genetic background. Hyperoxaluria was induced by adding hydroxyproline (HP) to the drinking water. A dose-response (0–2% HP) study found that both SS and BN exhibited the same level of oxalate excretion as HP concentration increased, but only the BN exhibited changes in urothelial pathology and demonstrated crystal deposition at sites of urothelial injury as a function of dose (at 1.5–2.0%). The consomic panel was treated with 2.0% HP and evaluated for hyperoxaluria, renal injury, and crystal deposition. Tubular injury (% Area) and crystal deposition (% Area) were similar between the resistant SS and SS-4, -6, -7, -8, -9, -11, -16, and -20BN consomic rats. However, tubular injury was significantly increased in SS-2BN compared with the SS parental (9.8 ± 1.56 and 4.2 ± 1.09%, respectively). Crystal deposition was observed in SS-2BN and SS-18BN (4.7 ± 0.70 and 3.5 ± 1.3%, respectively) to the same extent as seen in the susceptible BN (3.2 ± 0.44%). The fact that crystal deposition was observed in SS-18BN without extensive overall tubule injury, compared with the more severe widespread tubular injury seen in SS-2BN, suggests that the underlying mechanism of each locus is different. In conclusion, these studies establish that BN rats demonstrate oxalate-associated pathology and they retain calcium oxalate crystals coincident with urothelial injury but SS rats do not. These observations establish that BN rat chromosome 2 and 18 harbor genes that contribute to these processes.

Dahl S; spontaneously hypertensive rat; congenic strains; kidney stones



Address for reprint requests and other correspondence: N. S. Mandel, Medical College of Wisconsin, Dept. of Veterans Affairs Medical Center, 5000 W. National Ave., Milwaukee, WI 53295 (e-mail: nmandel{at}mcw.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.